In summary, our study demonstrates that ATM is aberrantly activated in a mouse model of α-synucleinopathy, and its pharmacological inhibition attenuates the DNA damage response, reduces neuroinflammation, and improves behavioral performance. Here, ATM is linked to synucleinopathy.